Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Updated DIfE – GERMAN DIABETES RISK TEST Optimized for Mobile Devices

22.06.2016

The German Institute of Human Nutrition (DIfE) has updated the online version of its German Diabetes Risk Score* and has optimized it for mobile devices. The test now takes into account the familial predisposition and is immediately accessible free of charge, both in German and English, at http://drs.dife.de/. The update is based on scientific results that the researchers at DIfE published jointly with colleagues from the German Center for Diabetes Research (DZD) in the journal Diabetes Research and Clinical Practice.

Advantages of the test


DIfE - GERMAN DIABETES RISK SCORE

DIfE

The Diabetes Risk Score was created in 2007, and since then it has been continuously developed further by DIfE and DZD scientists. The test is based on the data of the Potsdam EPIC** study, a long-term study of diet and health, in which more than 27,000 women and men are participating.

By means of the test, adults can easily, quickly and very precisely determine their personal risk of developing type 2 diabetes within the next five years. One of the main advantages of the online test is that at the end of the test you are given individually customized recommendations on how to reduce your risk.

You can try out directly how much you can influence your risk, for example by lowering the value you entered for your waist circumference, or by increasing your value for whole wheat bread consumption. Another new feature is that you can compare your test result on a graph with an average person of the same age and sex. This helps you to better assess your personal result in the appropriate context.

Why it’s important to know your personal diabetes risk

The disease develops slowly over years so that it is often detected too late – namely not until there is already end organ damage. Whoever takes the test and detects an elevated or even a high risk can undertake measures to counteract the outbreak of the disease and even undergo diabetic drug treatment if necessary.

The disease and the resulting damage can be prevented or at least significantly delayed by early and targeted preventive or therapeutic measures. You can find out how to take simple measures to prevent the disease at https://pc14.dife.de/get/tvwssp.

Type 2 diabetes and its serious consequences

In Germany around six million people are affected by diabetes. Of these, more than 90 percent suffer from type 2 diabetes. This is not a trivial disorder – if untreated it can lead to blindness, amputations, kidney failure, heart attacks or stroke. According to the Robert Koch Institute, diabetes is one of the most expensive chronic diseases and burdens the German health system with costs running into the billions ***.

Literature:

K. Mühlenbruch et al. 2014: Update of the German Diabetes Risk Score and External Validation in the German MONICA/KORA study. Diabetes Research and Clinical Practice (doi:10.1016/j.diabres.2014.03.013)

K. Mühlenbruch et al. 2014: Vorhersage des Risikos für Typ-2-Diabetes in der deutschen Bevölkerung mit dem aktualisierten DRT (DIfE - DEUTSCHER DIABETES-RISIKO-TEST®). Ernährungsumschau 6/2014; p. 90ff, M306
https://www.ernaehrungs-umschau.de/fileadmin/Ernaehrungs-Umschau/pdfs/pdf_2014/0....

Background information:

* The DIfE – GERMAN DIABETES RISK SCORE is available both as online test and in two different questionnaire versions for private individuals or patients. The test was validated using data of the Heidelberg EPIC study, the Tübingen Family Study for Type 2 Diabetes, the study “Metabolic Syndrome Berlin Potsdam” and the MONICA/KORA study (MONItoring trends and determinants in CArdiovascular disease/Cooperative Health Research in the Region of Augsburg). All test versions enable a very precise determination of the individual diabetes risk of a person for the next five years. The test was developed by DIfE using public funds (Federal Government, State of Brandenburg, European Union). The further development of the test is taking place within the framework of DZD research.

** EPIC: European Prospective Investigation into Cancer and Nutrition. The EPIC study is a prospective study which investigates the relationships between diet, cancer and other chronic diseases such as type 2 diabetes. Twenty-three administrative centers in ten European countries with a total of 519,000 adult participants are involved in the study. The Potsdam EPIC study, with more than 27,000 participants, is part of the EPIC study.

*** GBE Compact: Statistics and Trends from the Health Report of the Federal Government; Diabetes mellitus; Robert Koch Institute 3/2011 Vol. 2 (in German only)
http://www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/...

Pictures are available for 28 days under https://pc14.dife.de/get/azb82m.

The German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) is a member of the Leibniz Association. It investigates the causes of diet-related diseases in order to develop new strategies for prevention and therapy and to provide dietary recommendations. Its research focus includes the causes and consequences of the metabolic syndrome, which is a combination of obesity, high blood pressure, insulin resistance and lipid metabolism disorder, as well as the role of diet in healthy aging and the biological basis of food choices and eating habits. More information at www.dife.de. In addition, the DIfE is a partner of the German Center for Diabetes Research (DZD), which was founded in 2009 and has since been funded by the BMBF. More information on the DZD can be found at http://www.dzd-ev.de.

The Leibniz Association is the umbrella organization for 88 independent research institutions whose spectrum encompasses the natural, engineering and environmental sciences, economics, the spatial and social sciences as well as the humanities. Leibniz Institutes address issues of social, economic and ecological relevance. They conduct knowledge-driven and applied basic research, also in the overarching Leibniz research networks, as well as maintain scientific infrastructure and provide research-based services. The Leibniz Association sets priorities in knowledge transfer, in particular with the Leibniz research museums. It provides advice and information for policymakers, academia, business and industry and the general public. Leibniz Institutes collaborate intensively with universities – in the form of “Leibniz Science Campi” (thematic partnerships between university and non-university research institutes), for example – as well as with industry and other partners in Germany and abroad. They are subject to a standard-setting, transparent and independent evaluation procedure. Due to the importance of the Leibniz Institutes for Germany as a whole, they are funded jointly by the federal government and state governments, employing some 18,100 individuals, including 9,200 researchers. The overall budget of the institutes amounts to more than EUR 1.6 billion. More information at http://www.leibniz-gemeinschaft.de.

Contact:

Prof. Dr. Matthias Schulze
Department of Molecular Epidemiology
German Institute of Human Nutrition
Potsdam-Rehbruecke (DIfE)
Arthur-Scheunert-Allee 114-116
14558 Nuthetal/Germany
phone: +49 33200 88-2434
e-mail: mschulze@dife.de


Media Contact:

Dr. Gisela Olias
Coordinator for Press and Public Relations
German Institute of Human Nutrition
Potsdam-Rehbruecke (DIfE)
phone.: +49 33200 88-2278/-2335
e-mail: olias@dife.de
or presse@dife.de
http://www.dife.de

Weitere Informationen:

http://www.dife.de/diabetes-risiko-test/?lang=en German Diabetes Risk Score

Dr. Gisela Olias | idw - Informationsdienst Wissenschaft

Further reports about: DIfE Diabetes EPIC Ernährungsforschung chronic diseases type 2 diabetes

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>